Effect of calcium hydroxide on inflammatory root resorption and ankylosis in replanted teeth compared with other intracanal materials: a review
- Author:
Maryam ZARE JAHROMI
1
;
Mahmood Reza KALANTAR MOTAMEDI
Author Information
- Publication Type:Review
- Keywords: Calcium hydroxide; Root resorption; Tooth ankylosis; Tooth avulsion; Tooth replantation
- MeSH: Acetazolamide; Ankylosis; Bandages; Calcium Hydroxide; Calcium; Dental Enamel; Diphosphonates; Gallium; Indomethacin; Miners; Pemetrexed; Replantation; Root Resorption; Tooth Ankylosis; Tooth Avulsion; Tooth Replantation; Tooth
- From:Restorative Dentistry & Endodontics 2019;44(3):e32-
- CountryRepublic of Korea
- Language:English
- Abstract: Calcium hydroxide (CH) is the gold-standard intracanal dressing for teeth subjected to traumatic avulsion. A common complication after the replantation of avulsed teeth is root resorption (RR). The current review was conducted to compare the effect of CH with that of other intracanal medications and filling materials on inflammatory RR and replacement RR (ankylosis) in replanted teeth. The PubMed and Scopus databases were searched through June 2018 using specific keywords related to the title of the present article. The materials that were compared to CH were in 2 categories: 1) mineral trioxide aggregate (MTA) and endodontic sealers as permanent filling materials for single-visit treatment, and 2) Ledermix, bisphosphonates, acetazolamide, indomethacin, gallium nitrate, and enamel matrix-derived protein (Emdogain) as intracanal medicaments for multiple-visit management of avulsed teeth prior to the final obturation. MTA can be used as a single-visit root filling material; however, there are limited data on its efficacy due to a lack of clinical trials. Ledermix and acetazolamide were comparable to CH in reducing RR. Emdogain seems to be an interesting material, but the data supporting its use as an intracanal medication remain very limited. The conclusions drawn in this study were limited by the insufficiency of clinical trials.
